Under the leadership of Professor David Sebag-Montefiore, RadNet Director, and Professor Ann Henry, Deputy Director and in partnership with Leeds Teaching Hospitals NHS Trust, the RadNet Leeds strategy will deliver individualized precision radiotherapy for kinder, smarter treatment of primary and previously irradiated cancer by integrating biology, functional and anatomical imaging, artificial intelligence (AI) and with novel agents through three overarching research themes:
- Theme 1 – Personalised and Adaptive Radiotherapy
- Theme 2 – Re‑irradiation: from discovery to delivery
- Theme 3 – Radiotherapy response and resistance
Professor David Sebag-Montefiore

Professor of Clinical Oncology
Staff Profile: Professor David Sebag-Montefiore | School of Medicine | University of Leeds
Professor Ann Henry

Professor, Clinical Oncology
Staff Profile: Professor Ann Henry | School of Medicine | University of Leeds